Jarushka Naidoo, Consultant Medical Oncologist at Beaumont Hospital and Full Professor at Royal College of Surgeons in Ireland, shared a post on X about an article Brandon R. Block and colleagues authored:
“Can we treat cutaneous irAEs with a steroid-sparing approach?
– propensity-matched analysis of dupillimab (anti-IL4) v 2 control cohorts (n=204)
– 89% resolution with dupi
– ↑OS: dupi v controls HR 0.24 p<0.002
Answer: YES”
Title: Morbidity and Mortality Outcomes of Dupilumab for Cutaneous Immune-Related Adverse Events
Authors: Brandon R. Block, Jaanvi Mehta, Shayan Owji, Dan Feng, Thomas U. Marron, Nicholas Gulati,
Read Full Article.
More posts featuring Jarushka Naidoo on OncoDaily.